enquirer.com

News
Front Page
Local
Sports
-Bengals
-Reds
-Bearcats
-Xavier
Business
Health
Technology
Weather
Traffic
Back Issues
Photographs
AP Wire
-World
-Nation
-Sports
-Business
-Arts
-Health

Classifieds
Jobs
Autos
General
Obits
Homes

Freetime
Movies
Dining
Calendars
Weekend

Opinion
Columns
Borgman

GoCinci
HelpDesk
Feedback
Circulation
Subscribe
Phone #'s
Search

E N Q U I R E R   L O C A L   N E W S   C O V E R A G E
Thursday, May 20, 1999

Girl's last try for cure fails


Calif. family came here for new leukemia drug

BY TIM BONFIELD
The Cincinnati Enquirer

        Medicine ran out of miracles Wednesday for 14-year-old Merisa Rojas.

        The California girl and her father had stayed in Cincinnati for several weeks as she became the nation's first pediatric patient to try what researchers still hope will be a breakthrough treatment for leukemia.

        Merisa died Wednesday morning at her home in Hollister, Calif., surrounded by family members. “We knew it was a matter of time,” said her father, Fred Rojas. “But she was at home. It was peaceful. Now she's in a better place.”

        Merisa was diagnosed in 1997 with acute myeloid leukemia (AML), a type of blood cancer that affects about 9,400 people a year, according to the American Cancer Society. A flurry of treatments was attempted — all failed to put her disease into remission.

        In April, the Rojas family came to Children's Hospital Medical Center in hopes of a miracle. Here, doctors are testing an experimental “smart drug” made by Wyeth-Ayerst Laboratories that's designed to kill leukemia cells in a novel way.

        The drug — best known by its target, a protein called CD-33 — combines a powerful chemotherapy medicine with an antibody designed to hunt down cancer cells while leaving normal cells undamaged. After early research in adults showed some positive results, Merisa became the first of 20 to 40 pediatric leukemia patients expected to try the drug.

        Merisa received two doses of the “smart drug.” It knocked out the leukemia for a short while, “but the disease came roaring back,” said Dr. Robert Arceci, director of hematology/oncology at Children's Hospital Medical Center.

        On April 23, Merisa was flown back to California. She died 26 days later.

        Friends and relatives recalled a kind, attractive, outgoing young woman who particularly enjoyed the song “Angel” by Sarah McLachlan.

        Mr. Rojas, an imposing-looking man practically covered in tattoos, revealed himself to be a tender father who adored his daughter so much that he regularly made her bed at the Ronald McDonald House, then laid out jewelry on her pillow for her to wear.

        Even though the treatment failed to cure her disease, Mr. Rojas said his daughter was proud to be involved in the experiment.

        “I feel the doctors did learn something from Merisa along the way,” Mr. Rojas said.

        Dr. Arceci said Merisa's death does not prove that the drug doesn't work. Merisa had an advanced case of leukemia.

        “There is no question in my mind that this approach will be the future of therapy for this disease. We just have to figure out how to do it right. Unfortunately, that takes time,” Dr. Arceci said.

        So far, five children have been enrolled in the CD-33 study. At least one has had positive results, Dr. Arceci said. It will take many more months to get a better picture of whether the drug helps and whether it triggers serious side effects.

        If failures dominate the study, CD-33 will fade from the scene like many hundreds of drugs proposed every year to fight cancer and other diseases.

        No matter how the research turns out, doctors say — and her father knows — that Merisa made a difference.

       



J.J.'s babies are endless gift to neighborhood
Police shooting called fatal error
Report evokes wait-and-see reaction
Girl, 7, expelled in cap-gun case
Venues remove violent games
What's best for downtown?
Ujima festival gets $150,000 from city
Ohio House backs Commandment monuments at schools
Police deny shooting in raid
Schools awash in charter ideas
Budget bill would erase boundaries
Lawmakers doubt numbers in Kentucky gaming study
Patton seeks higher gasoline tax
Private donor offers bonus reward money
Art makes students' points about violence and abuse
Robots now fix hearts
Contenders in line for shot at Lucas
Writer's images of Ky. haunting
GET TO IT
It's Commonly Jazz series returns to toot its horn
'Take a Stand' helps teens talk about anger, violence
45 arrests after Kings Island 'Grad Night'
Agencies pinched by rising needs
Colerain road will be wider
Council rejects change to intimidation law
County's radio system costs $4.9M
Covington clinic marks anniversary
Covington party ends in slaying
Finan spurns aid plea
Furnish found guilty in killing
- Girl's last try for cure fails
Harper competent, could die Tuesday
Hostile e-mails case over
Lebanon manager praised as innovator
Lebanon recall leaves sour taste for many
Meister's attorney won't give up photos
Music room better than ever after fire
Nye urges scrapping proposal
Paint-ball gun brings boy's arrest
Repeat DUI cases target of push for new law
Sisters can pursue claim of fraud against insurer
Tobacco sales to underage dip
TRISTATE DIGEST
Ventura's dismissal request denied


 
Search | Questions/help | News tips | Letters to the editors
Web advertising | Place a classified | Subscribe | Circulation

Copyright 1995-2000. The Cincinnati Enquirer, a Gannett Co. Inc. newspaper.
Use of this site signifies agreement to terms of service updated 4/5/2000.